Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/1996
09/26/1996CA2215700A1 Aromatic compounds useful as tachykinin antagonists
09/26/1996CA2215699A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents
09/26/1996CA2215322A1 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
09/26/1996CA2215106A1 N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors
09/26/1996CA2211448A1 Rage tumor rejection antigens
09/26/1996CA2190865A1 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/25/1996EP0733644A1 Glucagon-like insulinotropic complexes, compositions and methods
09/25/1996EP0733642A1 Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions
09/25/1996EP0733628A1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
09/25/1996EP0733627A1 Thiophene compounds, a method for their preparation and pharmaceutical compositions containing them
09/25/1996EP0733626A1 N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists
09/25/1996EP0733620A1 Alpha-substituted-1-benzyl-naphthyls
09/25/1996EP0733213A1 Process for the production of combinatorial compound libraries
09/25/1996EP0733109A1 Bmp-12, bmp-13 and tendon-inducing compositions thereof
09/25/1996EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
09/25/1996EP0733103A1 Generation of high titers of recombinant aav vectors
09/25/1996EP0733069A1 Purified primate ctla-8 antigens and related reagents
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0733052A1 Bicyclene derivatives, their production and use
09/25/1996EP0733051A1 Bicyclic heterocycles as neurokinin a antagonists
09/25/1996EP0733044A1 Compounds
09/25/1996EP0733043A1 Tricyclic derivatives and their use in pharmaceuticals
09/25/1996EP0733041A1 Anthracene spiro-pyrrolidines as immuno-modulators
09/25/1996EP0733040A1 Piperazine-substituted pyrroloanthracene as immuno-moderators
09/25/1996EP0733039A1 Substituted pyrroloanthracenes and pyrroloanthracene diones as immunomodulators
09/25/1996EP0733035A1 Tricyclic derivatives, pharmaceutical compositions containing them
09/25/1996EP0733033A1 Pharmaceutically active substituted aromatic compounds
09/25/1996EP0732942A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
09/25/1996EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
09/25/1996EP0732938A1 Method of treating intestinal disorders
09/25/1996EP0732930A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
09/25/1996EP0732924A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent
09/25/1996EP0732919A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
09/25/1996EP0732915A1 Local delivery of fibrinolysis enhancing agents
09/25/1996EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
09/25/1996EP0674513B1 Retroviral protease inhibiting compounds
09/25/1996CN1131942A HIV protease inhibitors
09/25/1996CN1131939A Oxidizer carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and antitumor agents
09/25/1996CN1131907A Skin patches and methods for providing testosterone
09/25/1996CN1131674A Glucagon insulinotropic complexes, compositions and methods
09/25/1996CN1131665A Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation
09/25/1996CN1131560A Tonic wine capable of protecting kidney and strengthening bone
09/25/1996CN1131555A Pilose antler blood oral liquor
09/25/1996CN1131550A Pearl oral liquor capable of clearing away heart-fire
09/25/1996CN1131539A Treatment of disease and conditions associated with macrophage infiltration
09/25/1996CN1032856C Process for the preparation of novel ccylals of imidazole-5-carboxylic acid derivatives
09/24/1996US5559232 Anticoagulants
09/24/1996US5559213 Polyethylene-protein conjugates
09/24/1996US5559158 Pharmaceutical composition
09/24/1996US5559153 Antiarrhythmia agents; cardiovascular disorders
09/24/1996US5559152 Pharmaceutical composition having antiacoholic activity
09/24/1996US5559143 Anxiolytics, antidepressants, hypotensive agents, treatment of migraine
09/24/1996US5559137 Pyrazoles, arthritis treatment
09/24/1996US5559136 Treatment of Alzheimer's disease using azacyclic compounds
09/24/1996US5559132 Carboxamide derivatives for treating asthma
09/24/1996US5559131 Antagonists of tachykinins at the neurokinin 2 receptor, antiasthma
09/24/1996US5559113 Imidazole compounds and their therapeutic applications
09/24/1996US5559111 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
09/24/1996US5559103 Inhibition of cellullar binding to a selectin receptor
09/24/1996US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies
09/24/1996US5558085 Intrapulmonary delivery of peptide drugs
09/24/1996CA2087145C Composition for accelerating wound healing
09/24/1996CA2026418C Polypeptides useful as blockers of calcium channels
09/22/1996CA2150080A1 Glucagon-like insulinotropic complexes, compositions and methods
09/19/1996WO1996028730A1 Method of identifying molecules that regulate fgf activity
09/19/1996WO1996028543A1 New defined enzyme mixtures for obtaining cells and treating wounds
09/19/1996WO1996028470A2 Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
09/19/1996WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
09/19/1996WO1996028463A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028462A1 17-difluoromethylene-oestratrienes
09/19/1996WO1996028441A1 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
09/19/1996WO1996028187A1 Method for treating amyloidosis
09/19/1996WO1996028186A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
09/19/1996WO1996028167A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6
09/19/1996WO1996028151A2 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs
09/19/1996WO1996028148A2 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
09/19/1996WO1996028146A1 Novel naphthyl pharmaceutical compounds
09/19/1996WO1996017865A3 Genes and gene products for use in the diagnosis of degenerative nerve damage
09/19/1996WO1996010999A3 Lta4 hydrolase inhibitor pharmaceutical compositions and methods of use
09/19/1996DE19509729A1 17-Difluormethylen-Estratriene 17-difluoromethylene estratrienes
09/19/1996CA2215391A1 Method of identifying molecules that regulate fgf activity
09/19/1996CA2215201A1 17-difluoromethylene-estratrienes
09/19/1996CA2215061A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2214416A1 Novel naphthyl pharmaceutical compounds
09/19/1996CA2213723A1 New defined enzyme mixtures for obtaining cells and treating wounds
09/18/1996EP0732334A1 Piperidine derivatives, process for their preparation and their therapeutic application
09/18/1996EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals
09/18/1996EP0731810A1 Double-chain hemoregulatory peptides
09/18/1996EP0731792A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
09/18/1996EP0731791A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action
09/18/1996EP0731790A1 Tachykinin antagonists
09/18/1996EP0731789A1 Dp-iv-serine protease inhibitors
09/18/1996EP0731788A1 Prolyl endopeptidase inhibitors
09/18/1996EP0731787A1 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
09/18/1996EP0731699A1 Method of reducing body fat in animals by the administration of conjugated linoleic acid
09/18/1996EP0731697A1 Ssi tyrphostins and pharmaceutical compositions
09/18/1996EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups
09/18/1996EP0643780B1 Multiple solvent cleaning system
09/18/1996EP0565631B1 Anti-viral compounds
09/18/1996EP0553248B1 Novel 5-iodo-6-amino-1,2-benzopyrones and their analogs useful as cytostatic and antiviral agents
1 ... 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 ... 1564